Medical News

RSS

K-V secures $20 million loan from U.S. Healthcare

K-V Pharmaceutical Company announced today that it has entered into an agreement with U.S. Healthcare I, L.L.C. and U.S. Healthcare II, L.L.C. for a $20 million loan secured by assets of the Company. K-V will utilize the proceeds of the loan for working capital and general operating purposes.

15 Sep 2010

AAPCHO launches campaign to raise chronic hepatitis B awareness

The U.S. Department of Health and Human Services' Office of Minority Health, the Hepatitis B Foundation and the Association of Asian Pacific Community Health Organizations (AAPCHO) today launched a new campaign to raise awareness of the epidemic of chronic hepatitis B among Americans of Asian and Pacific Islander heritage.

15 Sep 2010

ITS commences treatment in synthetic universal influenza vaccine Phase I trial

Immune Targeting Systems (ITS) Limited, one of the leading developers of synthetic vaccines for mutating viruses, today announced the first patient has been treated in its Phase-I trial with its synthetic universal influenza vaccine (FP-01). Commencement of trials follows receipt of UK Regulatory Authority (MHRA) approval. Over the same period the company brought in £500,000 new investment from Esperante Ventures (UK).

15 Sep 2010

Sun Pharmaceutical announces expiration of Tender Offer for purchase of Taro Pharmaceutical shares

Sun Pharmaceutical Industries Ltd. today announced the expiration of the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), to purchase all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro) for $7.75 per Ordinary Share.

15 Sep 2010

USAID opens budget office, agency will assume more responsibility for its resources

USAID Administrator Rajiv Shah recently told agency staff "of the creation of the new USAID Office of Budget and Resource Management (BRM), to be led by his senior budgetary advisor Mike Casella," Foreign Policy's blog, "The Cable," reports, adding that this will "give USAID an increased role in developing and then justifying parts of its own budget going forward."

15 Sep 2010

FDA extends PDUFA date for AstraZeneca's ticagrelor NDA

AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has extended the time to complete its review of the New Drug Application (NDA) for ticagrelor (BRILINTA).

15 Sep 2010

Stanford Cancer Center to use TrueBeam radiation therapy technology for cancer patients

On Thursday, Sept. 16, the Stanford Cancer Center will become the first treatment center on the West Coast and the fifth in the world to offer cancer patients the TrueBeam, a machine that represents an exponential leap forward in the speed, power and precision of radiation therapy.

15 Sep 2010

Scientist to develop antibiotics for drug-resistant superbugs

Antibiotics can work miracles, knocking out common infections like bronchitis and tonsillitis. But according to the Center for Disease Control, each year 90,000 people in the U.S. die of drug resistant "superbugs" bacteria like Staphylococcus aureus (MRSA), a deadly form of staph infection resistant to normal antibiotics. Although hospital patients are particularly susceptible as a result of open wounds and weakened immune systems, the bacteria can infect anyone. Dr. Micha Fridman of Tel Aviv University's Department of Chemistry is now developing the next generation of antibiotics designed to overcome this kind of bacteria. And the key, he says, is in the bacteria itself.

15 Sep 2010

EHSI applauds Sen. Specter's support for Stem Cell Research Advancement Act

Emerging Healthcare Solutions, Inc. cheered Sen. Arlen Specter's (D-Penn.) statement of support for the Stem Cell Research Advancement Act on Monday.

15 Sep 2010

MVI agrees to provide fund for evaluating Inovio's malaria DNA vaccine candidate in non-human primates

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the PATH Malaria Vaccine Initiative (MVI) has agreed to provide follow-on funding to continue evaluation and development of Inovio's malaria DNA vaccine candidate in non-human primates.

15 Sep 2010

Children as young as 4 understand irony

New research findings from the Universit- de Montr-al reveals that children as young as four are able to understand and use irony. This study, published recently in the British Journal of Developmental Psychology, may impact the way parents communicate with their family.

15 Sep 2010

Senate amendments to strike health reform tax reporting provision fail

The Associated Press/Bloomberg Business: "The Senate failed Tuesday to repeal or ease an arcane tax reporting provision of the new health care law. ...Tucked into the health law is a requirement that businesses file tax forms called 1099s with the Internal Revenue Service for every vendor that sells them more than $600 in goods.

15 Sep 2010

Danny Davis to discuss diabetes, obesity rates in U.S. at UIC Midwest Conference

U.S. Rep. Danny Davis (D-Chicago) will give opening remarks when the Institute of Medicine of the National Academies convenes a regional meeting Sept. 21 at the University of Illinois at Chicago to discuss the rapidly rising rates of diabetes and obesity in the U.S.

15 Sep 2010

Ricerca Biosciences collaborates with Instem to innovate drug safety studies

Ricerca Biosciences, is pleased to announce the successful result of a partnership with Instem, a leading provider of laboratory data and information management solutions. The collaboration resulted in the development of a novel approach to eliminating potential misdosing during drug safety studies.

15 Sep 2010

Compandia is now CompanDX

Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies.

15 Sep 2010

NBCA arms healthcare professionals to 'Stop the Clot'

The National Blood Clot Alliance (NBCA) is making available an easily accessible, no-cost online curriculum for nurses, nurse practitioners, physician assistants, and pharmacists to help increase understanding about the diagnosis and treatment of blood clots and blood clotting disorders.

15 Sep 2010

Hunger costs developing nations $450B per year, report says

"Reduced worker productivity, poor health and lost education caused by malnourishment" is costing poor nations $450 billion a year, according to a report by the aid agency ActionAid, Agence France-Presse reports (9/13). The number is "more than 10 times the estimated amount needed to meet the United Nations Millennium Development Goal (MDG) of halving global hunger by 2015, said the report" according to the U.K. Press Association, which added that hunger also results in premature deaths (9/13).

15 Sep 2010

Study on spinal cord stem cells paves way for post stroke symptom treatment

Neuralstem, Inc. announced that its spinal cord stem cells survived in rat brains affected by stroke and differentiated predominantly into neurons. The transplanted animals showed significant improvement in some motor skill and strength measurements. The study entitled, "Intracerebral Implantation of Adherent Human Neural Stem Cells To Reverse Motor Deficits in Chronic Stroke Rats," was presented earlier today by senior study author, Dr. Shinn-Zong Lin, M.D., Ph.D., at the Stem Cells USA & Regenerative Medicine Conference

15 Sep 2010

AMRI selects compound for advanced preclinical testing in treatment of IBS

AMRI today announced the selection of a compound from its proprietary research program for the treatment of irritable bowel syndrome (IBS) for advanced preclinical testing, with the goal of submitting an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration (FDA) in 2011.

15 Sep 2010

Kansas Governor to head nursing home group after leaving office in January

Kansas City Star: "Parkinson, a Democrat, will be president and CEO of the American Health Care Association/National Center for Assisted Living, a non-profit, Washington-based trade and lobbying organization representing 11,000 nursing homes and assisted living centers." Before becoming lieutenant governor, Parkinson used to run a chain of long-term care facilities. He assumed the governor's job after Kathleen Sebelius left that post to become secretary of health and human services under President Barack Obama (Klepper, 9/13).

15 Sep 2010